Renae Boerneke, PharmD, BCPS, CPP


Clinical Pharmacist Practitioner, Infectious Diseases

Residency Associated Title and Involvement

Preceptor for Infectious Disease/HIV Clinic; Focus on OPAT (Outpatient Parenteral Antimicrobial Therapy) and Outpatient Stewardship


Undergraduate: Point Loma Nazarene University

School of Pharmacy: University of the Pacific Thomas J. Long School of Health Sciences

PGY1: VA San Diego

PGY2: VA San Diego- Infectious Disease

Rotation Title

Infectious Diseases Clinic Longitudinal Experience

Rotation Description:

The ambulatory care infectious diseases rotation for the PGY2 ID resident provides training in the area of adult infectious diseases and ambulatory care medicine through a multidisciplinary approach in the Infectious Diseases Clinic. Patients seen in the ID Clinic are managed by a variety of providers including Attending ID Physicians, ID Physician Fellows, Mid-Level Providers, and Clinical Pharmacist Practitioners. This rotation is a longitudinal experience for the PGY2 ID resident. The resident will complete a one-month rotation followed by a longitudinal experience (one half-day, once per week). The resident will provide patient education and provider consultations. In addition, the pharmacy specialist schedules established patients and bills insurance in conjunction with the patient’s primary provider. The resident will also participate in the care of those patients.

HIV/Hepatitis C: The resident receives training focused on the medications used to treat HIV and Hepatitis C including mechanism of action, common adverse drug reactions and side effects, and drug-drug interactions. The resident will be involved in engagement and retention of care by providing education, adherence counseling, and recommendations for antiretroviral therapy and drug-drug interactions.

OPAT: The resident will focus on pharmacotherapy of infectious disease through participation on the OPAT Team. The resident will be responsible for monitoring weekly safety labs, performing pharmacokinetics and dose adjustments of antimicrobial therapy when indicated, and providing recommendations for alternative therapy if ADRs occur.

For more information contact:

Kamakshi Rao

Kamakshi Rao, PharmD, BCOP, CPP, FASHP
Assistant Director, Academic Enterprises and Research Programs